Evogene Ltd. - Ordinary Shares — Cash Flow (NASDAQ:EVGN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -19.51 M-24.72 M-23.68 M-21.58 M-19.7 M-13.5 M — Cash from investing activities 9.41 M-20.57 M13.27 M-4.54 M9.62 M17.74 M — Cash from financing activities 20.37 M30.28 M9.34 M18.15 M4.66 M-6.6 M — Free cash flow -19.51 M-24.72 M-23.68 M-21.58 M-19.7 M-13.5 M —

News

Evogene Ltd. (EVGN) Q1 2026 Earnings Call Transcript

Evogene earnings missed by $0.20, revenue topped estimates

Evogene refocuses on AI drug discovery platform ChemPass

Evogene announces warrant inducement deal for $3.4 million

Evogene stock rises as company expands Google Cloud collaboration

Evogene expands Google Cloud collaboration to enhance AI platform

Evogene appoints two professors to scientific advisory board

Evogene stock soars after licensing deal for cancer therapeutic

Evogene subsidiary licenses cancer microbiome therapy to Lishan Biotech

Evogene announces CFO resignation and interim appointment

Evogene appoints Dr. Olga Nissan as VP of business development

Earnings call transcript: Evogene reports Q3 2025 earnings beat amid restructuring